Srilatha Edupuganti MD
[Pronunciation: Sri]
Professor, Medicine, Emory University School of Medicine
Join to View Full Profile
80 Jesse Hill Jr Dr SEAtlanta, GA 30303
Phone+1 404-778-7717
Dr. Edupuganti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North CarolinaMPH, Epidemiology, 2005
Emory University School of MedicineFellowship, Infectious Disease, 1995 - 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1992 - 1995
Louisiana State University School of Medicine in New OrleansClass of 1992
Certifications & Licensure
GA State Medical License 1995 - 2025
NC State Medical License 1997 - 2018
LA State Medical License 1994 - 1995
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- HVTN Citizenship Award HIV vaccine trials network, 2019
- Paper of the year International Society of Vaccines, 2017
- Member of Alpha Omega Alpha Honor Medical Society 1992
Clinical Trials
- Human Immune Responses to Yellow Fever Vaccination Start of enrollment: 2008 May 01
- Measles, Mumps, and Rubella (MMR) Immunity in College Students Start of enrollment: 2010 Mar 01
- Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine Start of enrollment: 2019 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085.Deborah A Theodore, Moni Neradilek, Kevin Gillespie, Srilatha Edupuganti, Juan Carlos Hinojosa
Journal of Acquired Immune Deficiency Syndromes. 2025-04-01 - Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people with...Tariro D Chawana, Stephen R Walsh, Lynda Stranix-Chibanda, Zvavahera M Chirenje, Chenchen Yu
BMC Immunology. 2025-02-19 - 1 citationsRare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.Maria C Hesselman, Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer Mamrosh
Cell Host & Microbe. 2025-02-12
Press Mentions
Emory University Participating in First-of-Its-Kind HIV Vaccine TrialJuly 21st, 2022- Emory Participating in Trial to Test mRNA HIV Vaccine in HumansJune 7th, 2022
- The Only Way We’ll Know When We Need COVID-19 BoostersJune 23rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
